JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 3,625 articles

Articles by James Calloway

Accenture Shares Swing Wildly Ahead of Q3 Earnings Report
Earnings

Accenture Shares Swing Wildly Ahead of Q3 Earnings Report

Accenture shares fell 4.7% this week to $178.25 as investors await June 18 Q3 results, with focus on bookings and AI demand after record $22.1 billion Q2 bookings.

ACN
Cooper Companies Surges 8.6% Despite Broader Market Selloff, Strategic Review in Focus
Earnings

Cooper Companies Surges 8.6% Despite Broader Market Selloff, Strategic Review in Focus

Cooper Companies rose 8.6% on Friday to $67.34, outperforming a sharp market decline, as investors focused on better-than-expected quarterly profit and the ongoing strategic review of its CooperSurgical unit.

COO
Paramount-Warner Merger Faces State Lawsuit Threat, WBD Shares Drop
Regulation

Paramount-Warner Merger Faces State Lawsuit Threat, WBD Shares Drop

Warner Bros. Discovery shares fell 3.6% on reports that states plan to sue to block the Paramount Skydance deal, widening the discount to the $31 cash offer.

WBD
TerraVest Plunges 30% on Insider-Tipping Probe
Regulation

TerraVest Plunges 30% on Insider-Tipping Probe

TerraVest shares plunged over 30% after the board launched a review into allegations that Executive Chairman Charles Pellerin shared privileged information before the EnTrans deal.

BioCardia Surges on FDA Minutes Showing CardiAMP Trial Can Support PMA
Regulation

BioCardia Surges on FDA Minutes Showing CardiAMP Trial Can Support PMA

BioCardia shares surged 52% to $1.40 after FDA meeting minutes confirmed its CardiAMP HF II trial may support a PMA for heart-failure cell therapy, bucking a weak biotech sector.

BCDA XBI IBB CAPR
Costco Gas Sales Surge 14.5% in May, Membership Fee Remains Key
Earnings

Costco Gas Sales Surge 14.5% in May, Membership Fee Remains Key

Costco reported a 14.5% sales surge in May, driven by booming gasoline sales and higher prices. Net sales reached $24.01 billion, with shares climbing $16.40 to $988.75.

COST WMT
Pennsylvania Bill Targets Data Centers as Electricity Prices Surge
Regulation

Pennsylvania Bill Targets Data Centers as Electricity Prices Surge

Pennsylvania House Republicans propose forcing large data centers to secure their own power and pay grid costs after electricity prices jumped statewide June 1.

Lululemon Plunges 12% Premarket on Weak Forecast, North American Woes
Earnings

Lululemon Plunges 12% Premarket on Weak Forecast, North American Woes

Lululemon shares dropped 12% premarket after cutting its annual profit forecast and issuing a weak Q2 outlook, as North American demand falters and margins shrink.

LULU
Guidewire Stock Drops Despite Earnings Beat as ARR Guidance Disappoints
Earnings

Guidewire Stock Drops Despite Earnings Beat as ARR Guidance Disappoints

Guidewire Software shares plunged 13.77% after hours as investors focused on a narrow miss in annual recurring revenue guidance, despite the company beating earnings and revenue estimates.

GWRE
Verizon Stock Falls on Supreme Court Ruling Despite Dividend Assurance
Regulation

Verizon Stock Falls on Supreme Court Ruling Despite Dividend Assurance

Verizon shares fell 3.8% due to a Supreme Court ruling against wireless carriers over FCC fines, despite a reaffirmed dividend. The stock's 6.3% yield draws income investors, but regulatory and debt challenges persist.

VZ T TMUS
Samsara Shares Dip Despite Q1 Beat as Tepid Guidance Tempers Enthusiasm
Earnings

Samsara Shares Dip Despite Q1 Beat as Tepid Guidance Tempers Enthusiasm

Samsara shares declined after the company beat Q1 estimates but issued Q2 guidance that barely exceeded forecasts, raising concerns about limited upside despite strong ARR and cash flow.

IOT
DocuSign Stock Dips Despite Strong Q1 Results as AI Growth Concerns Linger
Earnings

DocuSign Stock Dips Despite Strong Q1 Results as AI Growth Concerns Linger

DocuSign shares fell 4.2% after hours despite a Q1 earnings and revenue beat, as near-consensus guidance fueled doubts about the pace of AI-driven growth.

DOCU